[1]
Berden, F., van Zwietering, I., Maan, R., de Knegt, R., Kievit, W. and Drenth, J. 2016. High Risk of Infection During Triple Therapy with First- Generation Protease Inhibitors: A Nationwide Cohort Study. Journal of Gastrointestinal and Liver Diseases. 25, 2 (Jun. 2016), 197-204. DOI:https://doi.org/10.15403/jgld.2014.1121.252.th3.